Clinical Characteristics and Treatment Outcome of Six Advanced G3 Well-Differentiated Neuroendocrine Tumors

#1171

Introduction: According to 2010 WHO grading system, all neuroendocrine neoplasms were divided into G1/G2/G3 based on Ki-67 and mitotic count. However, differentiation was also very important for the biological behavior and treatment strategy.

Aim(s): This study focused on G3 well-differentiated neuroendocrine tumor (G3-WDNET), and demonstrated clinical characteristics and different treatment regimens for these patients.

Materials and methods: Differentiation of 43 G3 patients from January 2012 to November 2014 in our hospital were reexamined.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Jia R, Chen H, Chen Y, Ge F, Liu R,

Keywords: neuroendocrine neoplasms, well differentiated G3, medical treatment,